RhumbLine Advisers’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,183
| Closed | -$65K | – | 3111 |
|
|
2022
Q1 | $65K | Buy |
1,183
+120
| +11% | +$6.59K | ﹤0.01% | 2952 |
|
|
2021
Q4 | $104K | Sell |
1,063
-10
| -0.9% | -$978 | ﹤0.01% | 2936 |
|
|
2021
Q3 | $271K | Buy |
1,073
+413
| +63% | +$104K | ﹤0.01% | 2805 |
|
|
2021
Q2 | $204K | Buy |
660
+121
| +22% | +$37.4K | ﹤0.01% | 2919 |
|
|
2021
Q1 | $355K | Buy |
+539
| New | +$355K | ﹤0.01% | 2638 |
|